Vol 13, No 2 (April 30, 2025): Annals of Translational Medicine

Promising results with the daily oral small molecule lipoprotein(a) inhibitor, muvalaplin, in high-risk cardiovascular patients with elevated lipoprotein(a) levels

Early restrictive versus liberal oxygen for trauma patients: does it make a difference?

Olverembatinib for heavily pretreated BCR::ABL1-positive leukemia, including resistance or intolerance to ponatinib and/or asciminib

The association of hemorrhoids with the incidence of heart failure: a nationwide cohort study

Using half-hitch knots to uncouple surgical knot security and loop tautness

Effect of isometric resistance exercise on blood pressure in normotensive adults: a systematic review of randomized clinical trials

Optical coherence tomography retinal imaging: narrative review of technological advancements and clinical applications

Advances in personalized medicine: translating genomic insights into targeted therapies for cancer treatment

All that glitters ain’t gold

Erratum to aloe-emodin inhibits the proliferation, migration, and invasion of melanoma cells via inactivation of the Wnt/beta-catenin signaling pathway

Erratum to butyrate ameliorates alcoholic fatty liver disease via reducing endotoxemia and inhibiting liver gasdermin D-mediated pyroptosis

Erratum to Transthyretin-induced increase in circ_0007411 represses neovascularization of human retinal microvascular endothelial cells in hyperglycemia via the miR-548m/PTPN12/SKP1/EGFR pathway

Retraction: hsa_circ_0000006 induces tumorigenesis through miR-361-3p targeting immunoglobulin-like domains protein 1 (LRIG1) in osteosarcoma